Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)

The summary for the Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed): The purpose of this NOFO is to support the Pediatric HIV/AIDS Cohort Study (PHACS) as a transformative and agile program addressingthe developmental and clinical course of persons living with HIV, and vertically acquired HIV, with an emphasis on youth through reproductive age.

Federal Grant Title:	Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education, Health, Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-HD-25-003
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.121, 93.242, 93.279, 93.855, 93.865
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 11th, 2024
Original Application Deadline:	December 11th, 2024
Posted Date:	August 16th, 2024
Creation Date:	August 16th, 2024
Archive Date:	January 16th, 2025
Total Program Funding:
Maximum Federal Grant Award:	$5,500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	August 16th, 2024

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-25-003.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Interventions to expand cancer screening and preventive services to ADVANCE health in popu...; • Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative A...; • Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development o...; • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...; • Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial...; • Epidemiological and Behavioral Research in Oral Health; • Metagenomic Analyses of the Oral Microbiome; • Phase Iii Clinical Trials in Oral Infectious Diseases
More Grants from the National Institutes of Health: • Interventions to expand cancer screening and preventive services to ADVANCE health in popu...; • Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative A...; • Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Tria...; • NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clin...; • Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported R...